Professor David Cameron

Professor of Oncology, University of Edinburgh and Director of Cancer Services, NHS Lothian
Professor David Cameron

Professor David Cameron

Professor of Oncology, University of Edinburgh and Director of Cancer Services, NHS Lothian
Back

Biography

Professor Cameron’s first degree was in mathematics from the University of Cambridge, and he received his medical degree in 1986 from St. George’s Hospital Medical School, London. After completing a fellowship and MSc in Clinical Oncology at the University of Edinburgh, he received a M.D. with distinction in 1997 and completed his training as a medical oncologist that same year. Professor Cameron is a member of several professional societies including the American Society of Clinical Oncology & the European Society for Medical Oncology. He has also been a member of the EORTC task force on the use of growth factors in chemotherapy for solid tumours and lymphoma and a past chairman of the EORTC Breast Cancer group and the New Agent Committee. He is a past member of the Scottish medicines Consortium and chairs the Scottish short-life working group on the use of unlicensed cancer medicines.

He is active in a number of clinical trials in breast cancer. He is a member of the executive committee of the HERA adjuvant herceptin trial, and a member of the steering group for several UK adjuvant breast cancer trials (AZURE, OPTION, TACT, TANGO, MAMMO50, ARTEMIS, PERSEPHONE, ROSCO and TEAM) as well as the BIG APHINITY, ALTTO/NEO_ALTTO, BRAVO and AURORA studies. He is chief investigator on the recently reported UK trial adjuvant breast cancer trial, TACT2, and of BEATRICE, a global trial that tested the possible benefit of adjuvant bevacizumab in triple negative breast cancer.

Between November 2006 & June 2010 he was Director of the NIHR-funded National Cancer Research Networks, and at the end of 2009 was appointed as Professor of Oncology at Edinburgh University and Director of Cancer Services in NHS Lothian. In this role he is the clinical director of the Edinburgh Cancer Research Centre (including the CRUK funded Edinburgh Cancer Centre and the joint Edinburgh-Dundee Experimental Cancer Medicine Centre), and has responsibility for oversight and strategy of clinical and translational research in cancer in Edinburgh. He continues his major clinical interest in breast cancer with an on-going clinical and translational research programme. He is a past and/or present member of several cancer research funding committees including INCA PHRC, PEAR, Cancer Research UK Science and Clinical Research committees and from time to time NIHR funding bodies. He is also the Chief Scientist’s Office Clinical Cancer Research Champion in Scotland to act as a focal point for current and future clinical research in cancer in Scotland.

Sessions by Professor David Cameron

Key Note Lecture: Professor David Cameron

16:10-16:40
Exchange Auditorium